Autolus Therapeutics (AUTL) Misses Q3 EPS by 1c

Autolus Therapeutics (NASDAQ: AUTL) reported Q3 EPS of ($0.26), $0.01 worse than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Baidu (BIDU) PT Lowered to $150 at Benchmark on Near-Term Margin Concerns
• Viking Holdings Ltd (VIK) Tops Q2 EPS by 36c